Key Highlights
-
Demand Surge: Continuous growth in progesterone capsules and gels, driven by HRT and fertility treatments.
-
Strong exports and rising manufacturing costs are elevating global prices.
-
Prices expected to rise steadily into Qx xxxx amid stable logistics and persistent demand.
Pharmaceutical sales within the U.S. for Progesterone have been high, especially in hormone therapy and treatment of reproductive issues. Progesterone product downstream sales increased consistently, driven by increasing prescriptions and hospital demand for hormone replacement therapy (HRT), fertility treatment, and other uses in the market. Most notably, in the therapeutic groups, gels and progesterone capsules registered double-digit growth, driven by pre-Qx stockpiling and robust consumer healthcare expenditure. Progesterone demand gains were additionally fueled by increased awareness of women&#xx;s health problems and wider insurance coverage for hormonal therapies.
This regular use built a strong demand for progesterone active...
